Hemolytic uremic syndrome in a 65-year-old male linked to a very unusual type of stx2e- and eae-harboring O51:H49 Shiga toxin-producing Escherichia coli

Journal of Clinical Microbiology

Volumn 52, Issue 4, 2014, Pages 1301-1303

  Fasel, Dominique ^a   Mellmann, Alexander ^b   Cernela, Nicole ^c   Hac̈hler, Herbert ^c   Fruth, Angelika ^d   Khanna, Nina ^a   Egli, Adrian ^a   Beckmann, Christiane ^e   Hirsch, Hans H ^a,e   Goldenberger, Daniel ^a   Stephan, Roger ^c  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c UNIVERSITY OF ZURICH   (Switzerland)

^d ROBERT KOCH INSTITUTE   (Germany)

^e UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; BUDENOFALK; C REACTIVE PROTEIN; CREATININE; CYCLOSPORIN; GANCICLOVIR; LEVOFLOXACIN; MEROPENEM; METHOTREXATE; METHYLPREDNISOLONE; PREDNISONE; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY; VALGANCICLOVIR; ADHESIN; EAEA PROTEIN, E COLI; ESCHERICHIA COLI PROTEIN; VEROTOXIN 2; VIRULENCE FACTOR;

ABDOMINAL PAIN; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATION; BLOOD CULTURE; CASE REPORT; CAUSE OF DEATH; COLON BIOPSY; CREATININE BLOOD LEVEL; CYTOMEGALOVIRUS INFECTION; DIARRHEA; DISEASE ASSOCIATION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FATALITY; GASTROENTERITIS; GASTROINTESTINAL INFECTION; GRAFT FAILURE; GRAFT VERSUS HOST REACTION; HEMODIALYSIS; HEMOLYSIS; HEMOLYTIC UREMIC SYNDROME; HOSPITALIZATION; HUMAN; HUMAN TISSUE; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; INTENSIVE CARE; KIDNEY FAILURE; LEUKOCYTE COUNT; MALE; MULTIPLEX POLYMERASE CHAIN REACTION; MYELODYSPLASTIC SYNDROME; NEUTROPHIL ENGRAFTMENT; PLASMAPHERESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RARE SPECIES; RASH; SEPSIS; SHIGA TOXIN PRODUCING ESCHERICHIA COLI; THROMBOCYTOPENIA; TREATMENT OUTCOME; VIRUS REPLICATION; COMPLICATION; ESCHERICHIA COLI INFECTIONS; GENETICS; HEMOLYTIC-UREMIC SYNDROME; ISOLATION AND PURIFICATION; MICROBIOLOGY; PATHOLOGY; SEROTYPE;

ADHESINS, BACTERIAL; AGED; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; FATAL OUTCOME; GASTROENTERITIS; HEMOLYTIC-UREMIC SYNDROME; HUMANS; MALE; SEPSIS; SEROGROUP; SHIGA TOXIN 2; SHIGA-TOXIGENIC ESCHERICHIA COLI; VIRULENCE FACTORS;

EID: 84897136771     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.03459-13     Document Type: Article

References (19)

1. Wong CS, Jelacic S, Habeeb RL, Watkins SL, Tarr PI. 2000. The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. N. Engl. J. Med. 342:1930-1936. http://dx.doi.org/10.1056/ NEJM200006293422601. (Pubitemid 30419087)
2. Seifert ME, Tarr PI. 2012. Therapy: azithromycin and decolonization after HUS. Nat. Rev. Nephrol. 8:317-318. http://dx.doi.org/10.1038/nrneph.2012.87.
3. Bielaszewska M, Mellmann A, Zhang W, Köck R, Fruth A, Bauwens A, Peters G, Karch H. 2011. Characterisation of the Escherichia coli strain associated with an outbreak of haemolytic uraemic syndrome in Germany, 2011: a microbiological study. Lancet Infect. Dis. 11:671-676. http://dx.doi.org/10. 1016/S1473-3099(11)70165-7.
4. Persson S, Olsen KE, Ethelberg S, Scheutz F. 2007. Subtyping method for E. coli Shiga toxin (verocytotoxin) 2 variants and correlations to clinical manifestations. J. Clin. Microbiol. 45:2020-2024. http://dx.doi.org/10.1128/JCM. 02591-06. (Pubitemid 46933951)
5. Johnson JR, Stell AL. 2000. Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise. J. Infect. Dis. 181:261-272. http://dx.doi.org/10.1086/315217. (Pubitemid 30049057)
6. Sonntag AK, Bielaszewska M, Mellmann A, Dierksen N, Schierack P, Wieler LH, Schmidtt MA, Karch H. 2005. Shiga toxin 2e-producing E. coli isolates from humans and pigs differ in their virulence profiles and interactions with intestinal epithelial cells. Appl. Environ. Microbiol. 71:8855-8863. http://dx.doi.org/10.1128/AEM.71.12.8855-8863.2005. (Pubitemid 41804023)
7. Stephan R, Zhang W, Bielaszewska M, Mellmann A, Karch H. 2009. Phenotypic and genotypic traits of Shiga toxin negative E. coli O157:H7/H-bovine and porcine strains. Foodborne Pathog. Dis. 6:235-243. http://dx.doi.org/10.1089/ fpd.2008.0205.
8. Clermont O, Bonacorsi S, Bingen E. 2000. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl. Environ. Microbiol. 66:4555-4558. http://dx.doi.org/10.1128/AEM.66.10.4555-4558.2000.
9. Paton JC, Paton AW. 1998. Pathogenesis and diagnosis of Shiga toxin-producing E. coli infections. Clin. Microbiol. Rev. 11:450-479. (Pubitemid 28379095)
10. Friedrich AW, Bielaszewska M, Zhang W, Pulz M, Kuczius T, Ammon A, Karch H. 2002. Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms. J. Infect. Dis. 185:74-84. http://dx.doi.org/10.1086/338115. (Pubitemid 34043019)
11. Brooks JT, Sowers EG, Wells JG, Greene KD, Griffin PM, Hoekstra RM, Strockbine NA. 2005. Non-O157 Shiga toxin-producing Escherichia coli infections in the United States, 1983-2002. J. Infect. Dis. 192:1422-1429. http://dx.doi.org/10.1086/466536. (Pubitemid 41401157)
12. Mellmann A, Bielaszewska M, Köck R, Friedrich AW, Fruth A, Middendorf B, Harmsen D, Schmidt MA, Karch H. 2008. Analysis of collection of hemolytic uremic syndrome-associated enterohemorrhagic Escherichia coli. Emerg. Infect. Dis. 14:1287-1290. http://dx.doi.org/10.3201/eid1408.071082.
13. Nguyen RN, Taylor LS, Tauschek M, Robins-Browne RM. 2006. Atypical enteropathogenic Escherichia coli infection and prolonged diarrhea in children. Emerg. Infect. Dis. 12:597-603. http://dx.doi.org/10.3201/eid1204.051112.
14. Kozub-Witkowski E, Krause G, Frankel G, Kramer D, Appel B, Beutin L. 2008. Serotypes and virutypes of enteropathogenic and enterohaemorrhagic Escherichia coli strains from stool samples of children with diarrhoea in Germany. J. Appl. Microbiol. 10:403-410. http://dx.doi.org/10.1111/j.1365-2672. 2007.03545.x.
15. Fröhlicher E, Krause G, Zweifel C, Beutin L, Stephan R. 2008. Characterization of attaching and effacing Escherichia coli (AEEC) isolated from pigs and sheep. BMC Microbiol. 8:144. http://dx.doi.org/10.1186/1471-2180-8- 144.
16. Mora A, López C, Dhabi G, López-Beceiro AM, Fidalgo LE, Díaz EA, Martínez-Carrasco C, Mamani R, Herrera A, Blanco JE, Blanco M, Blanco J. 2012. Seropathotypes, phylogroups, Stx subtypes, and intimin types of wildlife-carried, Shiga toxin-producing Escherichia coli strains with the same characteristics as human-pathogenic isolates. Appl. Environ. Microbiol. 78:2578-2585. http://dx.doi.org/10.1128/AEM.07520-11.
17. Beutin L, Krause G, Zimmermann S, Kaulfuss S, Gleier K. 2004. Characterization of Shiga toxin-producing E. coli strains isolated from human patients in Germany over a 3-year period. J. Clin. Microbiol. 42:1099-1108. http://dx.doi.org/10.1128/JCM.42.3.1099-1108.2004. (Pubitemid 38332832)
18. Pierard D, Huyghens L, Lauwers S, Loir H. 1991. Diarrhoea associated with E. coli producing porcine oedema disease verotoxin. Lancet 338:762. http://dx.doi.org/10.1016/0140-6736(91)91487-F.
19. Feng PC, Jinneman K, Scheutz F, Monday SR. 2011. Specificity of PCR and serological assays in the detection of E. coli Shiga toxin subtypes. Appl. Environ. Microbiol. 77:6699-6702. http://dx.doi.org/10.1128/AEM.00370-11.